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Abstract: Affecting a large percentage of human population herpes simplex virus (HSV) types -1 and -2 mainly cause
oral, ocular, and genital diseases. Infection begins with viral entry into a host cell, which may be preceded by viral
“surfing” along filopodia. Viral glycoproteins then bind to one or more of several cell surface receptors, such as
herpesvirus entry mediator (HVEM), nectin-1, 3-O sulfated heparan sulfate (3-OS HS), paired immunoglobulin-like
receptor , and non-muscle myosin-IIA. At least five viral envelope glycoproteins participate in entry and these include
gB, gC, gD and gH-gL. Post-entry, these glycoproteins may also facilitate cell-to-cell spread of the virus, which helps in
the evasion of physical barriers as well as several components of the innate and adaptive immune responses. The spread
may be facilitated by membrane fusion, movement across tight junctions, transfer across neuronal synapses, or the
recruitment of actin-containing structures. This review summarizes some of the recent advances in our understanding of
HSV entry and cell-to-cell spread.
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INTRODUCTION
The herpesviridae family consists of over 70 viral
species, eight of which, herpes simplex virus-1 (HSV-1),
herpes simplex virus-2 (HSV-2), varicella-zoster virus
(VZV), cytomegalovirus (CMV), human herpesvirus 6
(HHV-6), human herpesvirus 7 (HHV-7), human herpesvirus
8 (HHV-8) and Epstein-Barr virus, are pathogenic to humans
and may infect anywhere from thirty to over ninety percent
of the adult human population [1]. Herpesviruses are
characterized by linear, double-stranded DNA enclosed in
icosahedral capsids. About 15-20 tegument proteins enclose
the capsid, as well as a lipid bilayer membrane envelope
derived from host cells [2]. All herpes viruses enter into
latency after primary infection, establishing infection for the
lifetime of their hosts. From their latency, herpesviruses can
be reactivated, which has been correlated with a weakening
of a host’s immune defenses against the virus, to cause
various diseases [3]. These diseases often involve viral
shedding, or are contagious, allowing the spread of a specific
herpesvirus within a population.
Affecting a significant majority of the general populace,
herpes simplex virus 1 (HSV-1) represents one of the most
studied herpesviruses. It causes mainly oral and ocular
manifestations. Facial herpes causes an annual 500,000 cases
of herpes labialis, HSV infection of the lips, mouth, gums or
lip area [3]. After primary infection, HSV-1 enters periods of
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latency in the trigeminal or cervical ganglia, where it can be
reactivated to cause recurrent episodes of viral shedding at
the skin through lesions and sores. Asymptotic viral
shedding can also occur, as it was reported in over 90% of
adults and often the virus was shed without an indication of
shedding through a lesion or sore [4]. One can contract
HSV-1 through direct contact with sites of viral shedding, or
with mucocutaneous fluids, which can also carry the virus
[4]. Diseases caused by HSV-1 in the throat and mouth
include pharyngitis, tonsillitis, and gingivostomatitis, which
cause inflammation of pharynx and tonsils and swelling of
the gums [2]. Ocular HSV-1 infections lead to several
conditions, including stromal keratitis, blepharitis and
retinitis, which are inflammations of the cornea, eyelid and
retinarespectively [5]. In addition, immunocompromised
hosts can suffer from HSV encephalitis, visceral infections
including but not limited to pneumonitis, esophagitis, and
hepatitis.
HSV-2 affected 45 million people aged 14 years or above
in the United States alone and is the leading cause of
recurrent genital herpes cases worldwide [6]. Genital herpes
is characterized by painful ulcerated lesions and sores on the
genitalia, although it can be asymptotic as well. Genital
herpes increases the risk of contracting HIV by 2 or 3 times,
as it is believed that 40-60% of HIV patients show prior
infection with HSV-2 [6]. Schacker et al. repeatedly detected
HIV RNA in genital ulcers, while they reported a decrease in
HIV viral shedding with the healing of Genital Ulcer Disease
(GUD) [7]. Recurrent genital herpes is mainly caused by
HSV-2, as HSV-1 is less likely to be reactivated from the
sacral ganglia, where HSV-2 latency and reactivation occurs
[7]. Similar to HSV-1, HSV-2 can be contracted through
direct contact with sites of viral shedding, which occurs after
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reactivation of the virus from its latency in sacral ganglia.
Therefore, shedding of the virus from genital areas during
sexual intercourse is the main method of contracting or
spreading the virus [8].
However, there are additional methods of contracting
HSV-2 as well. Recent studies have placed emphasis on the
transfer of mainly HSV-2, but also HSV-1, from mother to
child. The most common method of vertical transfer of HSV
occurs during child birth through contact with an infected
birth canal. Neonates can also contract HSV through contact
with an HSV-infected caregiver or through ingestion of
infected maternal secretions, known as intrauterine
infections [9]. Neonatal infections by HSV-2 or HSV-1 pose
serious threats, as they often lead to fatal diseases. These
include SEM disease (disease located in the skin, eye or
mouth), herpes encephalitis, or dispersed multi-organ
infection [10]. HSV-2 can cause meningitis in neonates,
which is usually more severe and life-threatening than
Mollaret meningitis. The latter is a rare form of recurrent
meningitis also caused by HSV-2 in adults. Unlike neonatal
meningitis, it is aseptic, mild, and usually self-limiting.
HSV holds several factors that allow it to evade the
immune system, leading to chronic infection in the body.
HSV-1 glycoprotein gC binds C3b of the complement
cascade, preventing the formation of anaphylatoxin C5a, as
well as the formation of the Membrane attack complex
(MAC) [11]. MAC is normally responsible for disrupting the
phospholipid bilayer of infected cells, leading to cell lysis
and death. Also, The HSV-1 gene ICP47 binds to the peptide
transporter associated with antigen presentation, leading to
the prevention of peptides on the major histocompatibility
complex 1 (MHC1), thereby inhibiting the presentation of
viral antigens to cytotoxic T-cells [12]. Other virulence
factors include the gE-gI heterodimer, as well as viral host
shutoff protein (vhs). Vhs has several functions, which
include the prevention of production of IFN-, which works
with cytokines in intercellular signaling as well and plays a
role in antiviral response, through the reduced IRF7
activation. Additionally, vhs is able to suppress
proinflammatory cytokines and chemokines, inhibit antigen
presentation by MHCI and MHCII, and inhibit the
maturation of dendritic cells. The glycoproteins gE-gI have
been shown to inhibit the activation of the complement
cascade by binding to the Fc domain on IgG of antibodies
which activate the classical complement cascade [13].
Methods by which the virus enter host-cells and the
machinery that allow the virus to evade immune defenses,
including cell-to-cell spread, help establish lifelong infection
by HSV-1 and HSV-2.
ENTRY
HSV-1 and HSV-2 utilize several glycoprotein-receptor
complexes when entering into host cells (Fig. 1). Both
express the glycoproteins gB, gC, gD, gH, and gL. All
except gC are essential for host cell entry, although the
absence of gC does reduce efficiency [1]. gC makes the first
contact with the host cell, binding to heparan sulfate (HS)
proteoglycans on the cell surface. In the absence of gC, gB is
able to carry out this function. HSV-1 has been shown to
exercise several methods to attach to the host cell. In some
cases, HSV-1 travels down filopodia-like membrane
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protrusions to reach the cell body for internalization. This
extracellular transport of virions is called “surfing”(Fig. 1)
[14]. Exposure to HSV-1 can induce the formation of these
actin-rich, filopodia-like structures by the cell. This is
facilitated through members of the Rho GTPase family,
which have been shown to act as a link between surface
receptors such as syndecans or integrins and the actin
cytoskeleton organization underneath [15, 16]. At the
activation of these small GTPases, filopodia are formed. The
glycoprotein gB seems to regulate viral surfing, as it binds to
the HS expressed on the filopodia. Once the virus is bound,
it travels unilaterally to the cell surface, where gD proceeds
to bind with one of its four receptors (discussed below) and
the process of virus penetration and membrane fusion ensues
[14, 16-18].
GLYCOPROTEINS AND RECEPTORS IMPORTANT
FOR ENTRY
The glycoproteins gB and gH play a significant role in
membrane fusion, allowing the lipids in both the viral and
cell membranes to mix. Of all the glycoproteins involved in
entry, gB is the most conserved and is likely to function as a
membrane fusogen [19]. As a fusogenic protein it is quite
unique and has not been classified as either a class I or class
II fusion protein. In fact, it contains characteristics of both
classes; namely, an -helical coiled-coil core and extended 
hairpins [19]. In addition, multiple domains play crucial
roles in the functioning of gB [20]. Without gL, gH is only
poorly expressed at the cell surface and it may be structurally
immature [21, 22]. gL, therefore, has been implicated as a
kind of guide for gH, so that the latter is able to carry out its
function in cell entry [22]. The main purpose of gD is to bind
to a receptor on the cell surface to induce viral fusion to the
cell membrane [2, 23]. At the core of gD is a V-shaped
immunoglobulin domain and its flexible N-terminus folds
into a hairpin-like structure. Several residues on the Cterminus of gD regulate receptor binding [23, 24].
gD can use three different families of receptors to enter
into uninfected cells (Table 1). Herpesvirus entry mediator,
or HVEM, is one such receptor that aids in entry along with
its normal function within the tumor necrosis factor receptor
(TNFR) superfamily as a part of the process of apoptosis.
Normally, HVEM binds to LIGHT, a member of the tumor
necrosis factor (TNF) superfamily that activated T cells
express [25]. Nectin-1 and nectin-2, affiliated with the
immunoglobulin (Ig) family, have also been shown to act as
receptors [2]. Generally, these relatives of the poliovirus
receptor play a role in cell adhesion. While four nectins have
been discovered, only the aforementioned two can act as
receptors for HSV gD [26]. Finally, 3-O sulfated heparan
sulfate (3-OS-HS), a polysaccharide belonging to the HS
family and thus consisting of a basic structure of repeating
disaccharide units, can be used for entry [27-30]. However,
only specific isoforms of 3-OS-HS, resulting from the action
of certain 3-O-sulfotransferases, are able to bind to gD [27].
The receptors have been found to be specific to certain
types of cells. For example, nectin-1 is generally used by
herpesviruses entering epithelial cells [2]. In activated Tlymphocytes or Trabecular meshwork cells of the eye,
HVEM is the major receptor [26, 31]. In addition, the type of
virus can influence the receptor used. Nectin-2 has not
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Fig. (1). Genomic distribution of HSV glycoproteins involved in viral entry and cell-to-cell spread. A. Glycoprotein genes required for HSV1 entry and spread. HSV contains a 152-kb double-stranded linear DNA genome encoding over 80 viral genes that are arranged as unique
long (UL) and unique short (US) segments flanked by inverted repeat sequences (boxes). The inverted repeats contain sequences required for
cleavage/packaging of the viral genome. The genes encoding glycoproteins important for HSV-1 entry and spread are shown. B. Pathways of
HSV entry into cells. Two major pathways of entry (I) penetration by viral envelope fusion at the plasma membrane and (II) endocytosis are
shown.

shown significant results in helping wild-type HSV-1 entry,
while HSV-2 does not seem to use 3-OS HS [1, 26]. gB, on
the other hand, can use paired immunoglobulin-like receptor
alpha (PILR-) as a coreceptor for cell entry [32]. While
both types of the herpesvirus may use this receptor, it has
been proved ineffectual for HSV-2 [33]. In addition, the
binding of gB to PILR- may aid in evading the immune
system by sending inhibitory signals to the host cell.
Recently gB was also shown to bind non-muscle myosin
heavy chain IIA [34]; however, a clear significance of this
interaction is not well established. Furthermore, similar to
gB, gH also has two receptors that may aid in entry. B5,
which is a type 2 membrane protein that is able to form an helix for coiled-coils, can interact with other proteins
containing -helices such as HSV-1 gH, which may help it
facilitate HSV-1 fusion [35]. The functional effect on HSV
entry of the second possible receptor for gH, v3 integrins,
has not yet been well understood [36].
Likewise, very limited information is available on the
role of entry receptors in HSV-1 endocytosis [37]. Some

Table 1.

Cell Lines with Known gD Receptors
Cell Line (Virus)

Major Entry
Receptor

Human conjunctival epithelium (HSV-1)

Nectin-1, HVEM

Human corneal fibroblasts, primary (HSV-1)

3-OS HS

Human corneal fibroblasts, primary (HSV-2)

HVEM

Human corneal epithelium (HSV-1)

Nectin-1

Human Mesenchymal Stem Cells (HSV-1)

3-OS HS

Human Trabecular Meshwork Cells, primary (HSV-1)

HVEM

HeLa Cells (HSV-1, HSV-2)

Nectin-1, HVEM

Retinal pigment epithelial cells (HSV-1)

Nectin-1

Retinal pigment epithelial cells (HSV-2)

Nectin-1

Radial glial cells and Cajal-Retzius cells

Nectin-1

Neuronal cells (HSV-1, HSV-2)

Nectin-1
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recent studies have suggested that HSV-1 can induce
primary human corneal fibroblasts to engulf it in a form of
an atypical endocytosis. Because this method may not be pH
dependent and does not involve the use of clathrin-coated
vesicles or caveolae, the uptake of HSV into cells most
closely resembles phagocytosis [15]. This method may also
need actin rearrangement and dynamin assembly to function,
as well as the work of RhoA, a member of the Rho GTPase
family, and some PI3 kinases [15, 38]. As aforementioned,
HSV-1 induces the formation of protrusions from the cell
surface. Association with these protrusions, as well as the
clustering of gD receptors in large vesicles, marks this form
of uptake [15]. It is quite likely that the virus then fuses with
the membrane of an intra-cellular vesicle to release its capsid
into the cytosol [15]. Recently, it was demonstrated that
virus-cell fusion is also facilitated by syndecan-1 and
syndecan-2 proteoglycan core proteins, as it was found that
down-regulation of syndecan-1 and syndecan-2 led to a
statistically significant decrease in HSV-1 entry and
membrane fusion [39]. Since syndecans have been
implicated in endocytosis [40] it is possible that they help
with the virion fusion at a vesicular membrane. HSV-1
internalization via endosomes may allow virus to enter by
both ways, fusion of the viral envelope at the plasma
membrane and also by endocytosis. HSV-1 shows a very
broad host range and quite possibly, it may have evolved
versatile ways to enter into its multiple host cell-types.
Post fusion, the nucleocapsid and tegument proteins of
the virus are released into the cytoplasm of the cell through
the fusion pore. They are aided in their travel to the nucleus
by the dynein-dynactin protein complex, which some viral
tegument proteins may also take part in. The viral capsid
contains VP26, which interacts with two dynein light chains:
Tctex1 and rp3. VP26 attracts dynein to the viral capsid,
which then transports the virus along the microtubules (MT)
of the cell [41]. The virus is taken first to the microtubule
organizing center (MTOC) and then to the nucleus itself,
where it binds to the nuclear pore complexes (NPCs). The
viral DNA is released through these pores into the nucleus,
where viral replication will occur [41].
CELL-TO-CELL SPREAD
HSV-1 has the ability to use cell-to-cell spread to transfer
the virus between infected and uninfected cells. Rather than
using incessant infection of host epithelial and lymphocytic
cells to reproduce for more infection, cell-to-cell spread uses
various methods, including cell-to-cell fusion, virion fusion
across tight junctions, transfer across synapses and the
recruitment of actin-containing structures to spread the virus
directly from an infected to an uninfected cell. Proposals for
how these phenomena occur have been supported by studies
aimed to identify molecular details of the events.
Cell-to-cell fusion involves the fusion of plasma
membranes of infected and uninfected cells to form a
syncytial cell. However, a “microfusion” can occur where
the two cells fuse but remain structurally independent.
Theoretically, any cell with machinery needed for virus-cell
fusion can undergo cell-to-cell fusion with an infected cell.
The binding of HSV glycoprotein gD on an infected cell to
its receptors on uninfected cells is essential to both virus-cell
and cell-to-cell fusion [42-44]. In addition to gB, gH-gL,
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other glycoproteins including gE and gL, have been found as
essential to the process, as gE and gL form a heterodimer in
the trans-Golgi network (TGN) necessary for fusion of
epithelial cells, which can be halted by a disruption of early
sorting through the TGN [45]. Additionally, gK was found to
be a vital component of cell-to-cell fusion in corneal and
trigeminal ganglia cells, as mice infected with HSV-1
lacking gK displayed a significant decrease in cell-to-cell
fusion [46].
Several gD receptors have been shown to play roles in
cell-to-cell fusion, including HVEM, nectin-1 and 3-OS-HS.
Tiwari et al. found 3-O sulfated heparan sulfate to mediate
cell-to-cell fusion, as cells lacking the receptor showed a
significant decrease in cell-to-cell fusion [47]. O’Donnell &
Shukla recently found heparan sulfate to have a regulatory
role on cell-to-cell fusion in HeLa cells [48]. Involvement of
syndecans in cell-to-cell spread has also been reported [39].
Although little is known on conformational changes that
occur before and during fusion, unpublished data shows the
extension of an arm towards the uninfected cell as a means
of starting cell-to-cell fusion (O’Donnell and Shukla,
unpublished results). Currently, very limited information is
available on the structural details of cell fusion and
involvement of heavy changes in cytoskeleton is highly
suspected [15].
Cell-to-cell fusion is extremely advantageous for HSV-1.
Because HSV-1 replicates in the nucleus, syncytial cells,
which contain multiple nuclei, formed after fusion allow
increase in virus reproduction and spread. Additionally,
syncytial cellsallow HSV-1 to avoid innate and adaptive
immune defenses against the virus, which range from the
innate mediators of mucosal immunity to antibodies and
phagocytes that target HSV-1. However, cell-to-cell fusion
poses few disadvantages, which include the lack of the
ability to easily spread throughout various parts of the body.
Normally, the release of newly replicated viruses in blood
would allow them to quickly travel to the entire body, HSV1 is only rarely found in the blood [1,42].
CELL JUNCTIONS AND SYNAPSES IN
SPREAD

HSV-1

HSV-1 can also move across intercellular junctions,
which seal adjacent epithelial cells together to prevent
movement of small molecules and particles across barriers.
Several factors have been found to play roles in the
movement of HSV-1 across tight junctions, including
glycoproteins gB, gD, gH-gL and gE-gI [42]. HSV-1 can
bind to complexes involved in cell junctions, including
nectin-1, an entry receptor for HSV-1 and major component
of adherens junctions [49]. gE-gI possibly facilitates the
attachment of HSV-1 to intercellular junctions, as the
accumulation of gE-gI was observed to colocalize with
junction proteins including e-cadherins of human epithelial
cells, while it did not accrue at lateral surfaces that were not
in contact with other cells [50]. Because movement across
tight junctions is a form of cell-to-cell fusion, advantages
provided by this type of cell-to-cell spread include the ability
to avoid neutralizing antibodies and other innate and
adaptive immune defenses. The main disadvantage is that
cell-to-cell spread may be slower than the transport via blood
to various parts of the body.
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HSV-1 can be transferred across synapses of neurons, a
process which is not completely understood. gD, gB and gH-gL
are always necessary for trans-neuronal spread of HSV-1. The
virus can travel in an anterograde movement towards axon
termini in an infected neuron and be transferred across synaptic
space to other cells [27,42]. It is believed that gD induces the
formation of varicosities on neurons and can be transferred
between neurons or from the neuron to a non-neuronal cell. De
Regge et al. found that the addition of a soluble form of PRVgD in neurons infected with pseudorabies virus (PRV), a
member of the - herpesvirus family, resulted in the formation
of varicosities in 60-70 percent of axons [51]. Also, nectin-1
was found to play a role in the formation of varicosities, as the
addition of the antibody CK6, which binds the ectodomain of
nectin-1, resulted in the formation of varicosities on 70 percent
of cells [51]. The roles of gD and nectin-1 in the formation of
varicosities in PRV- infected cells suggests that they may also
play a role in the formation of varicosities in HSV-infected
cells, promoting the spread of the virus from neurons to other
cells.
HSV-1 can also recruit actin-containing structures for its
spread from cell-to-cell. Actin-containing membrane processes
project out from the cell, contacting neighboring cells and
allowing the movement of the virus from the protrusions to
neighboring cells. It has been found that the viral tegument
protein VP-16 accumulated in long protrusions from infected
cells and that these protrusions fused with neighboring cells to
allow the transfer of the virus from the infected to uninfected
cell [52]. The authors suggested that these protrusions may have
been related to actin-containing structures, which would
indicate that VP-16 may play a role in the extension of these
structures towards neighboring cells.
Because HSV-1 infects epithelial, and neuronal cells
including those in the eyes [53], cell-to-cell spread is critical for
its survival and ability to reach the trigeminal ganglia for the
establishment of latency. Epithelial cells and innervating nerve
endings usually are in close proximity with one another,
increasing the chances of cell-to-cell spread. Also, close
proximity increases chances of the formation of tight junctions
and infection of neurons encourages cell-to-cell spread through
transfer across synapses [27]. The whole thing is also likely to
be true with HSV-2 as well, since both are highly homologous
neurotropic viruses that commonly share entry receptors and
other cellular mediators of virus spread including cellular
motors for transport along the microtubules.
General advantages of cell-to-cell spread include evasion of
both innate and adaptive immune responses, which range from
the body’s physical barriers to phagocytes. For example, HSV-1
could infect mucosal cells, while it could not penetrate the high
viscosity mucosal membranes without cell-to-cell spread. Other
advantages include the speed in which cells are infected after
viral replication. Following a normal route of infection, newly
replicated viruses would exit the cell until locating new host
cells, a process which can consume large amounts of time,
making the virus increasingly susceptible to immune defense
mechanisms. As stated earlier, an advantage of the formation of
a syncytium with multiple nuclei is advantageous for HSV-1, as
it HSV-1 replicates in nuclei of host cells. Overall, cell-to-cell
spread, through membrane fusion, transfer across synapses,
recruitment of actin-containing structures, or movement across
tight junctions, provides numerous advantages to HSV-1,
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promoting pathogenesis of the virus. It may also represent one
of the strongest aspects of HSV-1 lifecycle that give the virus
the ability to survive for the lifetime of its host.
CONCLUSION
HSV can infect a wide variety of host cell types. One
important reason behind this is the versatile ability of the virus
to use multiple receptors and pathways for entry. Entry is also
perhaps the most critical step in viral lifecycle as it allows the
virus to initiate an infection that lasts for the lifetime of its host.
Regardless of HSV entry receptors or pathways utilized, the
initial infection almost always results in the establishment of
latency. Recent advances in the field of HSV cellular receptors
and HSV entry glycoproteins’ structures, interactions and
functions have broadened our understanding of the pathogen.
We are now much more knowledgeable about the identity of
HSV entry receptors. However, more progress is needed on
specific contributions of entry receptors, role of intracellular
signaling in HSV entry, and characterization of molecular
mechanisms that allow the virus to successfully evade host’s
immune system. Such knowledge will definitely help with the
development of new and potent HSV vaccines and anti-HSV
drugs. It is important that the huge prevalence of HSV in the
human population worldwide be controlled. Failing to do so will
continue to have strong implications for not just acquiring the
HSV-related diseases but also additional viral diseases, which
may be facilitated by a prior infection with HSV.
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